Open AccessDual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn’s disease: A case report and review of literature
Author(s) -
Michael Au,
Nikola Mitrev,
Rupert W. Leong,
Viraj C. Kariyawasam
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i8.2569
Subject(s) - medicine , vedolizumab , ocrelizumab , adverse effect , crohn's disease , disease , multiple sclerosis , clinical trial , oncology , intensive care medicine , immunology , rituximab , lymphoma